Dr. Bakhtier Nurmukhamedov, MD

Dr. Nurmukhamedov practices at Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health.

Dr. Nurmukhamedov's NPI, 1538535596, was assigned on August 13, 2015. Dr. Nurmukhamedov holds Maine license MD23260.

Dr. Nurmukhamedov's primary practice is Northern Light Eastern Maine Medical Center, at 489 State Street, Bangor, ME 04401 in Penobscot County. The practice phone is (207) 973-7000.

Dr. Nurmukhamedov's primary practice is Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health. Dr. Nurmukhamedov is also affiliated with MaineGeneral Medical Center. The medical group on file is Northern Light Eastern Maine Medical Center. Dmand AI also links Dr. Nurmukhamedov to 1 more hospital, 1 breast imaging center, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Nurmukhamedov's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nurmukhamedov practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nurmukhamedov's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Nurmukhamedov is licensed in Maine.

CMS data shows 139 Medicare services from Dr. Nurmukhamedov across 4 procedure codes in 2024, for 161 Medicare patients. Medicare paid $10,541 for them.

CMS counts 161 Medicare patients who saw Dr. Nurmukhamedov in 2024. The largest group is under 65, with 71 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 59% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nurmukhamedov's median patient age at 52, with 58% women.

In 2024, Dr. Nurmukhamedov wrote 1,277 Medicare Part D claims for 195 patients. 78% of them were for generic drugs. CMS names the drug for 1,146 of them, across 27 drugs with 11 or more claims each, at $586,776 in total drug cost. In 2023, CMS named 1,036 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Nurmukhamedov for performance year 2024, reported as part of a group. Dr. Nurmukhamedov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Nurmukhamedov from 6 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 65% of the total. Biogen, Inc. paid the most, $300.